Is LSB or NOBL a better dividend investment in 2026?

LSB currently yields 318.98% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: LSB offers higher current income.

What is the dividend yield difference between LSB and NOBL?

LSB has a forward dividend yield of 318.98% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 316.81 percentage points.

Home › Compare › LSB vs NOBL

LSB vs NOBL: Dividend Comparison 2026

LSB yields 318.98% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LSB wins by $2296.49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LSB

● Live price

318.98%

Share price

$0.63

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2296.51M

Annual income

$1,420,493,114.32

Full LSB calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — LSB vs NOBL

📍 LSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LSB	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LSB + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LSB pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSB

Annual income on $10K today (after 15% tax)

$27,113.24/yr

After 10yr DRIP, annual income (after tax)

$1,207,419,147.17/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, LSB beats the other by $1,207,418,934.86/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSB + NOBL for your $10,000?

LSB: 50%NOBL: 50%

100% NOBL50/50100% LSB

Portfolio after 10yr

$1148.27M

Annual income

$710,246,682.05/yr

Blended yield

61.85%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSB buys

NOBL buys

No recent congressional trades found for LSB or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLSBNOBL

Forward yield	318.98% ✓	2.17%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2296.51M ✓	$22.9K
Annual income after 10y	$1,420,493,114.32 ✓	$249.78
Total dividends collected	$2210.37M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LSB vs NOBL ($10,000, DRIP)

Year	LSB Portfolio	LSB Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$42,598	$31,897.93	$10,917	$217.08	+$31.7K → LSB
2	$172,569	$126,989.30	$11,903	$221.48	+$160.7K → LSB
3	$665,442	$480,792.73	$12,962	$225.68	+$652.5K → LSB
4	$2,444,714	$1,732,690.93	$14,099	$229.68	+$2.43M → LSB
5	$8,564,999	$5,949,155.42	$15,319	$233.49	+$8.55M → LSB
6	$28,643,738	$19,479,189.22	$16,628	$237.10	+$28.63M → LSB
7	$91,530,880	$60,882,080.00	$18,033	$240.53	+$91.51M → LSB
8	$279,758,876	$181,820,834.73	$19,539	$243.78	+$279.74M → LSB
9	$818,711,097	$519,369,100.17	$21,154	$246.86	+$818.69M → LSB
10	$2,296,513,989	$1,420,493,114.32	$22,884	$249.78	+$2296.49M → LSB

LSB vs NOBL: Complete Analysis 2026

LSB — Stock

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSB Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this LSB vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSB vs SCHD LSB vs JEPI LSB vs O LSB vs KO LSB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.